ResidualPlaybeta

Surgeon Simulator: Experience Reality

Bossa Studios · 2016 · $19.99 · Action · deal grade B

  • Estimated net residual revenue: $1.2k to $1.8k per month
  • Opportunity: $3.1k per month at x2.10 dormancy
  • Estimated lifetime owners: 61.3k
  • 58%% positive across 1257 reviews · 13.8 reviews/month

Why it's flagged

  • Developer silent for 4.5 years
  • Studio active elsewhere (6 titles tracked), so this one may welcome a partner
  • Last build shipped 4.5 years ago
  • Last discounted 1 months ago, 10 sales in the last 12 months
  • Proven demand elasticity: x1.7 review velocity during past deep sales

Analyst notes (AI-assisted)

A VR surgical-comedy game from 2016 that applies the Surgeon Simulator franchise to virtual reality with mixed technical results.

Surgeon Simulator: Experience Reality earned $263k lifetime on modest sales (61k units) and still generates $1.5k/mo residual revenue despite significant VR compatibility issues and a 58% positive rating. The title remains a logical franchise extension and owns recognizable IP, but requires substantial technical remediation to recover value. Best suited for a publisher with VR platform expertise and tolerance for a 12-18 month stabilization window. Most realistic play: publishing.

  • Risk: Frequent crash reports on SteamVR and Oculus platforms, particularly with Quest 2 via Virtual Desktop; controls described as unresponsive for core gameplay actions.
  • Risk: No developer posts in 54 months; codebase likely untouched through multiple VR API generational shifts, Unity/Unreal updates, and OS changes.
  • Risk: VR market skewed toward shorter engagement; 1-10h median playtime in reviews suggests limited depth or replayability despite $19.99 price point.
  • Risk: Cartoon aesthetic and simplified simulation depth position it below AAA VR competitors; niche comedy appeal is not broad enough to absorb QA/port costs.

This case as Markdown · Estimates carry ±30-50%% error per title.